Will the Phase 2 trial "Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)" reach primary completion on or before Dec 26, 2027?

Resolves Yes if ClinicalTrials.gov record NCT03407079 (National Institute on Alcohol Abuse and Alcoholism (NIAAA)) shows an actual primary completion date on or before Dec 26, 2027. Registered date at generation: Dec 26, 2027.

Outcome verified from clinicaltrials.gov.

1. Market open

   Jul 17, 2026, 7:40 AM UTC
2. Market closes

   By Dec 26, 2027, 11:59 PM UTC
3. Projected payout

   Shortly after the market closes

Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.